Malioxamycin is an antibiotic produced by S. lydicus that inhibits Gram-negative bacteria by inhibiting peptidoglycan synthesis in bacterial cell walls and promoting the formation of spheroplasts. Malioxamycin has been reported to inhibit E. coli and K. pneumoniae with MIC values of 50-100 μg/ml.